Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery.

Patrick P Starlinger David PereyraHubert HacklGregor OrtmayrEva BraunwarthJonas SantolSina NajarniaMichael R DriedgerLindsey GregoryRoberto Alva-RuizAmy GlasgowAlice AssingerDavid M NagorneyElizabeth B HabermannStefan StaetttnerSean P ClearyRory L SmootThomas Gruenberger

Published in: Hepatology (Baltimore, Md.) (2021)

We observed a significant association of perioperative SSRI/SNRI intake with adverse postoperative outcome after hepatic resection. This indicates that SSRIs/SNRIs should be avoided perioperatively in patients undergoing hepatic resections.

Keyphrases

patients undergoing
minimally invasive
cardiac surgery
coronary artery bypass
body mass index
physical activity
coronary artery disease
acute coronary syndrome
weight gain
liver metastases